Are Wall Street Analysts Predicting Insulet Stock Will Climb or Sink?

With a market cap of $18.4 billion, Insulet Corporation (PODD) is a global leader in developing innovative insulin delivery systems, including the Omnipod Insulin Management System, designed for people with insulin-dependent diabetes. It offers advanced solutions like Omnipod 5, Omnipod DASH, and Omnipod GO, enabling discreet and user-friendly insulin management. 

Shares of the Acton, Massachusetts-based company have outperformed the broader market over the past 52 weeks. PODD has risen 41.8% over this time frame, while the broader S&P 500 Index ($SPX) has rallied 32.1%. However, in 2024, shares of PODD are up 22.8%, lagging behind SPX’s 26.2% gain on a YTD basis.